These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 15492289

  • 1. Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling.
    Ji Q, Aoyama C, Nien YD, Liu PI, Chen PK, Chang L, Stanczyk FZ, Stolz A.
    Cancer Res; 2004 Oct 15; 64(20):7610-7. PubMed ID: 15492289
    [Abstract] [Full Text] [Related]

  • 2. Impaired dihydrotestosterone catabolism in human prostate cancer: critical role of AKR1C2 as a pre-receptor regulator of androgen receptor signaling.
    Ji Q, Chang L, Stanczyk FZ, Ookhtens M, Sherrod A, Stolz A.
    Cancer Res; 2007 Feb 01; 67(3):1361-9. PubMed ID: 17283174
    [Abstract] [Full Text] [Related]

  • 3. Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells.
    Wiebe JP, Lewis MJ.
    BMC Cancer; 2003 Mar 22; 3():9. PubMed ID: 12659654
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma.
    Lewis MJ, Wiebe JP, Heathcote JG.
    BMC Cancer; 2004 Jun 22; 4():27. PubMed ID: 15212687
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interleukin 1β regulates progesterone metabolism in human cervical fibroblasts.
    Roberson AE, Hyatt K, Kenkel C, Hanson K, Myers DA.
    Reprod Sci; 2012 Mar 22; 19(3):271-81. PubMed ID: 22064385
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
    Blouin K, Richard C, Brochu G, Hould FS, Lebel S, Marceau S, Biron S, Luu-The V, Tchernof A.
    J Endocrinol; 2006 Dec 22; 191(3):637-49. PubMed ID: 17170221
    [Abstract] [Full Text] [Related]

  • 15. Aldo-keto reductase 1C subfamily genes in skin are UV-inducible: possible role in keratinocytes survival.
    Marín YE, Seiberg M, Lin CB.
    Exp Dermatol; 2009 Jul 22; 18(7):611-8. PubMed ID: 19320734
    [Abstract] [Full Text] [Related]

  • 16. Localization and altered expression of AKR1C family members in human ovarian tissues.
    Ji Q, Aoyama C, Chen PK, Stolz A, Liu P.
    Mol Cell Probes; 2005 Aug 22; 19(4):261-6. PubMed ID: 15979276
    [Abstract] [Full Text] [Related]

  • 17. Expression of human aldo-keto reductase 1C2 in cell lines of peritoneal endometriosis: potential implications in metabolism of progesterone and dydrogesterone and inhibition by progestins.
    Beranič N, Brožič P, Brus B, Sosič I, Gobec S, Lanišnik Rižner T.
    J Steroid Biochem Mol Biol; 2012 May 22; 130(1-2):16-25. PubMed ID: 22245609
    [Abstract] [Full Text] [Related]

  • 18. Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3).
    Penning TM, Burczynski ME, Jez JM, Lin HK, Ma H, Moore M, Ratnam K, Palackal N.
    Mol Cell Endocrinol; 2001 Jan 22; 171(1-2):137-49. PubMed ID: 11165022
    [Abstract] [Full Text] [Related]

  • 19. Induction of AKR1C2 by phase II inducers: identification of a distal consensus antioxidant response element regulated by NRF2.
    Lou H, Du S, Ji Q, Stolz A.
    Mol Pharmacol; 2006 May 22; 69(5):1662-72. PubMed ID: 16478829
    [Abstract] [Full Text] [Related]

  • 20. AKR1C2 small interfering RNA (siRNA) inhibited beta-catenin expression and transcriptional activation in human liver cancer cell line QGY7701.
    Lu DD.
    Hepatogastroenterology; 2007 May 22; 54(79):2088-91. PubMed ID: 18251165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.